Caris Life Sciences, Inc. financial data

Symbol
CAI on Nasdaq
Location
Irving, TX
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 05 Nov 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 282,146,923 shares
Common Stock, Shares, Outstanding 282,103,259 shares
Common Stock, Value, Issued $283,000 USD
Weighted Average Number of Shares Outstanding, Basic 282,099,073 shares 691%
Weighted Average Number of Shares Outstanding, Diluted 297,211,838 shares 734%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $216,833,000 USD 113%
Research and Development Expense $21,624,000 USD -21.78%
Selling and Marketing Expense $41,267,000 USD 12%
General and Administrative Expense $51,973,000 USD 27%
Costs and Expenses $184,191,000 USD 13%
Operating Income (Loss) $32,642,000 USD
Nonoperating Income (Expense) $-8,317,000 USD -20.76%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $24,325,000 USD
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $24,325,000 USD
Earnings Per Share, Basic 0.09 USD/shares
Earnings Per Share, Diluted 0.08 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $753,221,000 USD
Marketable Securities, Current $2,272,000 USD
Accounts Receivable, after Allowance for Credit Loss, Current $26,697,000 USD
Other Assets, Current $2,577,000 USD
Assets, Current $854,245,000 USD
Property, Plant and Equipment, Net $63,997,000 USD
Goodwill $19,344,000 USD
Other Assets, Noncurrent $46,985,000 USD
Assets $984,571,000 USD
Accounts Payable, Current $28,999,000 USD
Accrued Liabilities, Current $56,867,000 USD
Contract with Customer, Liability, Current $2,791,000 USD
Liabilities, Current $86,030,000 USD
Operating Lease, Liability, Noncurrent $43,828,000 USD
Other Liabilities, Noncurrent $43,881,000 USD
Liabilities $506,207,000 USD
Accumulated Other Comprehensive Income (Loss), Net of Tax $748,000 USD
Retained Earnings (Accumulated Deficit) $-2,630,693,000 USD
Stockholders' Equity Attributable to Parent $478,364,000 USD
Liabilities and Equity $984,571,000 USD

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 2,800,000,000 shares
Common Stock, Shares, Issued 283,723,897 shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $756,982,000 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $24,404,000 USD
Property, Plant and Equipment, Gross $304,449,000 USD
Operating Lease, Liability, Current $6,450,000 USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100,000,000 shares
Additional Paid in Capital $3,124,943,000 USD
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $4,900,000 USD -53.33%
Share-based Payment Arrangement, Expense $13,655,000 USD 189%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares